Adenocarcinoma of Prostate Clinical Trial
Official title:
CDC SIP: Rochester Prevention Research Center: Development and Evaluation of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer
The overall goal of this project is to test an interactive, multi-media decision aid in the form of an electronic clinical decision dashboard designed to improve the quality of clinical decision making for initial treatment of patients with newly diagnosed, low or intermediate risk prostate cancer.
The overall goal of this project is to test an interactive, multi-media decision aid in the
form of an electronic clinical decision dashboard designed to improve the quality of clinical
decision making for initial treatment of patients with newly diagnosed, low or intermediate
risk prostate cancer.
Specifically, we propose to conduct a clinical trial to compare the effects of a prostate
decision dashboard versus usual care on:
1. patient knowledge regarding the treatment options available for low or intermediate risk
prostate cancer,
2. measures of the decision making process including decisional conflict and the extent to
which decisions were made via a shared decision making process,
3. the treatments selected, and
4. 3-6 and 9-12 month outcome assessments of clinical status, decision regret,
cancer-related quality of life including worry, functional status, and treatment side
effects.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02258087 -
HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.
|
Phase 2/Phase 3 | |
Recruiting |
NCT04687969 -
Multimodal Machine Learning Characterization of Solid Tumors
|
||
Recruiting |
NCT02672449 -
Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer
|
N/A | |
Active, not recruiting |
NCT01913717 -
Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion
|
N/A | |
Completed |
NCT02025361 -
Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy
|
Phase 4 | |
Completed |
NCT00140478 -
Mifepristone (RU-486) in Androgen Independent Prostate Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01952223 -
A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse
|
Phase 3 | |
Completed |
NCT03518853 -
Short Course Radiotherapy for Localized Prostate Cancer
|
N/A | |
Active, not recruiting |
NCT01994239 -
Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy
|
Phase 2 | |
Terminated |
NCT02024685 -
Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial
|
N/A |